Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

NCT00424177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Purpura, Thrombocytopaenic, Idiopathic

Interventions

DRUG: eltrombopag

Sponsor

GlaxoSmithKline